These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12094764)

  • 41. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
    Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
    Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
    Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
    Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of spinal nitric oxide synthase-dependent processes in the initiation of the micturition hyperreflexia associated with cyclophosphamide-induced cystitis.
    Lagos P; Ballejo G
    Neuroscience; 2004; 125(3):663-70. PubMed ID: 15099680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postnatal development of NOS-ir neurons in the rat claustrum.
    Kowiański P; Moryś JM; Wójcik S; Dziewiatkowski J; Moryś J
    Folia Morphol (Warsz); 2003 Feb; 62(1):11-7. PubMed ID: 12769172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effects of interferon-gamma on myocardial hypertrophy.
    Jin H; Li W; Yang R; Ogasawara A; Lu H; Paoni NF
    Cytokine; 2005 Sep; 31(6):405-14. PubMed ID: 16105741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension.
    Jurzik L; Froh M; Straub RH; Schölmerich J; Wiest R
    J Hepatol; 2005 Aug; 43(2):258-65. PubMed ID: 15963596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of beta 3-adrenoceptor in altered beta-adrenergic response in senescent heart: role of nitric oxide synthase 1-derived nitric oxide.
    Birenbaum A; Tesse A; Loyer X; Michelet P; Andriantsitohaina R; Heymes C; Riou B; Amour J
    Anesthesiology; 2008 Dec; 109(6):1045-53. PubMed ID: 19034101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Characteristic training-induced and pressure-induced cardiac hypertrophy in experimental animals].
    Kissling G; Puhm M; Medugorac I; Jacob R
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():388-9. PubMed ID: 148802
    [No Abstract]   [Full Text] [Related]  

  • 49. [Characteristics of myocardial hypertrophy in arterial hypertension of various origins and in atherosclerosis].
    Amineva KhK; Slepokurova LB; Fedosenko KV
    Arkh Patol; 1988; 50(8):36-9. PubMed ID: 2973782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of acute ischemia on myocardial cyclic AMP, phosphorylase a, and lactate levels in various forms of cardiac hypertrophy. Correlation with cardiac norepinephrine stores.
    Wollenberger A; Shahab LW; Krause EG; Genz S; Warbanow W; Nitschkoff S
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():551-9. PubMed ID: 4377609
    [No Abstract]   [Full Text] [Related]  

  • 51. Renal hypertension induced by a new procedure in the rat.
    Fekete A; Tarján E
    Acta Med Acad Sci Hung; 1973; 30(3):177-84. PubMed ID: 4274310
    [No Abstract]   [Full Text] [Related]  

  • 52. [On the pathogenesis of cardiac insufficiency].
    Hauss WH; Schmitt G; Junge-Hülsing G
    Z Kreislaufforsch; 1968 Mar; 57(3):201-12. PubMed ID: 4174601
    [No Abstract]   [Full Text] [Related]  

  • 53. [Distribution of nitric oxide synthase in human intracardiac ganglia].
    Shuklin AV; Shvalev VN
    Kardiologiia; 2006; 46(8):26-8. PubMed ID: 17047597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Contractile activity of the myocardium in experimental arterial hypertension].
    Gurgenian SV; Dolabchian ZL; Kovaleva NT; Trubetskoĭ AV
    Patol Fiziol Eksp Ter; 1974; 0(4):20-5. PubMed ID: 4280036
    [No Abstract]   [Full Text] [Related]  

  • 55. [Characteristics of the development of experimental renal hypertension].
    Frolov VA; Drozdova GA
    Dokl Akad Nauk SSSR; 1979; 246(4):1010-2. PubMed ID: 156634
    [No Abstract]   [Full Text] [Related]  

  • 56. Morphometry of cardiac hypertrophy induced by experimental renal hypertension.
    Wiener J; Giacomelli F; Loud AV; Anversa P
    Am J Cardiol; 1979 Oct; 44(5):919-29. PubMed ID: 158965
    [No Abstract]   [Full Text] [Related]  

  • 57. [Standardization of an experimental model of arterial hypertension capable of inducing cardiac hypertrophy].
    Bregagnollo EA; Cicogna AC; Spadaro J; Saiki PS; Tucci PJ
    Arq Bras Cardiol; 1981 Feb; 36(2):91-4. PubMed ID: 6459773
    [No Abstract]   [Full Text] [Related]  

  • 58. [Architecture of coronary vessels in experimental myocardial hypertrophy].
    Ljungqvist A; Unge G
    Nord Med; 1971 Apr; 85(15):481. PubMed ID: 4252510
    [No Abstract]   [Full Text] [Related]  

  • 59. [Reversibility of heart hypertrophy in hypertension].
    Widimský J
    Vnitr Lek; 1980; 26(12):1190-8. PubMed ID: 6451982
    [No Abstract]   [Full Text] [Related]  

  • 60. Cardiomyopathy: a role for nitric oxide?
    de Belder A; Moncada S
    Int J Cardiol; 1995 Jul; 50(3):263-8. PubMed ID: 8537150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.